Dr Chandra P. Leo, MBA

Over ten years of experience in private equity, clinical practice and biomedical research. Former principal at Wellington Partners Venture Capital, focusing on life science investments. Previously physician at University Hospital Leipzig (Germany), postdoctoral scientist at Stanford University (USA). Completed medical studies in Berlin and London, doctoral degree from Freie Universität Berlin (Charité), MBA degree with distinction from INSEAD. Former board member of ESBATech (acquired by Alcon), board observer at Anthera Pharmaceuticals (IPO NASDAQ) and Panomics (acquired by Affymetrix). Current board member of Cardiac Assist and Delenex Therapeutics, board observer at ChemoCentryx and Odyssey Thera.